Furthermore, gene ontology and pathway enrichment analyses indicate a regulatory role of microglial Nox2 in multiple pathways associated with MS/EAE, particularly the chemotactic factor, Pf4 (33). The gene discussed is PF4; the disease is myeloid sarcoma.